Cancer Research and Treatment

Original Articles

Breast cancer

The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12): Jae Sik Kim, Kyubo Kim, Wonguen Jung, Kyung Hwan Shin, Seock-Ah Im, Hee-Jun Kim, Yong Bae Kim, Jee Suk Chang, Jee Hyun Kim, Doo Ho Choi, Yeon Hee Park, Dae Yong Kim, Tae Hyun Kim, Byung Ock Choi, Sea-Won Lee, Suzy Kim, Jeanny Kwon, Ki Mun Kang, Woong-Ki Chung, Kyung Su Kim, Ji Ho Nam, Won Sup Yoon, Jin Hee Kim, Jihye Cha, Yoon Kyeong Oh, In Ah Kim; Cancer Res Treat. 2022;54(4):1121-1129. Published online December 31, 2021; DOI: https://doi.org/10.4143/crt.2021.1083

Abstract PDF Supplementary Material PubReader ePub

Purpose
We aimed to investigate manifestations and patterns of care for patients with brain metastasis (BM) from breast cancer (BC) and compared their overall survival (OS) from 2005 through 2014 in Korea.
Materials and Methods
We retrospectively reviewed 600 BC patients with BM diagnosed between 2005 and 2014. The median follow-up duration was 12.5 months. We categorized the patients into three groups according to the year when BM was initially diagnosed (group I [2005-2008], 98 patients; group II [2009-2011], 200 patients; and group III [2012-2014], 302 patients).
Results
Over time, the median age at BM diagnosis increased by 2.2 years (group I, 49.0 years; group II, 48.3 years; and group III, 51.2 years; p=0.008). The percentage of patients with extracranial metastasis was 73.5%, 83.5%, and 86.4% for group I, II, and III, respectively (p=0.011). The time interval between BC and BM was prolonged in patients with stage III primary BC (median, 2.4 to 3 years; p=0.029). As an initial brain-directed treatment, whole-brain radiotherapy alone decreased from 80.0% in 2005 to 41.1% in 2014. Meanwhile, stereotactic radiosurgery or fractionated stereotactic radiotherapy alone increased from 13.3% to 34.7% during the same period (p=0.005). The median OS for group I, II, and III was 15.6, 17.9, and 15.0 months, respectively, with no statistical significance.
Conclusion
The manifestations of BM from BC and the pattern of care have changed from 2005 to 2014 in Korea. However, the OS has remained relatively unchanged over the 10 years.

Citations

Citations to this article as recorded by

Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12)
Jae Sik Kim, Kyubo Kim, Wonguen Jung, Kyung Hwan Shin, Seock-Ah Im, Hee-Jun Kim, Yong Bae Kim, Jee Suk Chang, Jee Hyun Kim, Doo Ho Choi, Yeon Hee Park, Dae Yong Kim, Tae Hyun Kim, Byung Ock Choi, Sea-Won Lee, Suzy Kim, Jeanny Kwon, Ki Mun Kang, Woong-Ki C
Breast Cancer Research and Treatment.2023; 200(1): 37. CrossRef

8,517 View
195 Download
1 Web of Science
1 Crossref

High-Dose-Rate Brachytherapy for the Treatment of Vaginal Intraepithelial Neoplasia: Jin Ho Song, Joo Hwan Lee, Jong Hoon Lee, Jong Sup Park, Sook Hee Hong, Hong Seok Jang, Yeon Sil Kim, Byung Ock Choi, Sei Chul Yoon; Cancer Res Treat. 2014;46(1):74-80. Published online January 15, 2014; DOI: https://doi.org/10.4143/crt.2014.46.1.74

Abstract PDF PubReader ePub

PURPOSE
Vaginal intraepithelial neoplasia (VAIN), a rare premalignant condition, is difficult to eradicate. We assess the effectiveness of high-dose rate intracavitary brachytherapy (HDR-ICR) in patients with VAIN or carcinoma in situ (CIS) of the vagina after hysterectomy.
MATERIALS AND METHODS
We reviewed 34 patients treated for posthysterectomy VAIN or CIS of the vagina by brachytherapy as the sole treatment. All patients underwent a coloposcopic-directed punch biopsy or had abnormal cytology, at least 3 consecutive times. All patients were treated with a vaginal cylinder applicator. The total radiation dose was mainly 40 Gy in 8 fractions during the periods of 4 weeks at a prescription point of the median 0.2 cm (range, 0 to 0.5 cm) depth from the surface of the vaginal mucosa.
RESULTS
Acute toxicity was minimal. Seven patients had grade 1/2 acute urinary and rectal complications. There were 15 cases of late toxicity, predominantly vaginal mucosal reaction in 12 patients. Of these patients, two patients suffered from grade 3 vaginal stricture and dyspareunia continuously. After a median follow-up time of 48 months (range, 4 to 122 months), there were 2 recurrences and 2 persistent diseases, in which a second-line therapy was needed. The success rate was 88.2%. The average prescription point in failure patients was 1.1 mm from the surface of the vagina compared to an average of 2.6 mm in non-recurrent patients (p=0.097).
CONCLUSION
HDR-ICR is an effective treatment method in VAIN patients. In spite of high cure rates, we should consider issues regarding vaginal toxicity and radiation techniques to reduce the occurrence of failure and toxicity.

Citations

Citations to this article as recorded by

Treatment of cervical/vaginal intra-epithelial neoplasia with high–dose-rate brachytherapy: a multi-center retrospective analysis
Dong-Yun Kim, Choong-Won Lee, Wonguen Jung, Hyun-Cheol Kang, Eunji Kim, Won Il Jang, Kyung Su Kim
International Journal of Gynecological Cancer.2026; : 104466. CrossRef
Natural History of Primary Vaginal Intraepithelial Neoplasia With and Without Treatment: A Systematic Review and Meta-Analysis
Ugo Indraccolo, Chiara Borghi, Marta Mattei Gentili, Gennaro Scutiero, Emanuele Caselli, Alessandro Favilli
Clinical and Experimental Obstetrics & Gynecology.2025;[Epub] CrossRef
Analysis of the clinical efficacy of HIFU in the treatment of low-grade vaginal intraepithelial neoplasia
Jingxi Zhang, Xiang Li, Mengyu Chen, Biyao Jiang, Shiying Wu, Weiwei Hu, Juan Tao, Fang Xiao, Songshu Xiao
International Journal of Hyperthermia.2025;[Epub] CrossRef
Is robotic-assisted vaginectomy a better choice in vaginal high-grade squamous intraepithelial lesions than conventional laparoscopic surgery?
Yana Liu, Meng Mao, Jing Bai, Mingbo Cai, Qian Wang, Hanlin Fu, Mengling Zhao, Chunfang Wang, Lulu Si, Ruixia Guo
BMC Women's Health.2024;[Epub] CrossRef
Advances in the Treatment of High-Grade Stump Vaginal Intraepithelial Neoplasia after Total Hysterectomy
俐君刘
Advances in Clinical Medicine.2024; 14(04): 1555. CrossRef
Comprehensive evaluation of vaginal intraepithelial neoplasia development after hysterectomy: insights into diagnosis and treatment strategies
Jiahui Wei, Yumei Wu
Archives of Gynecology and Obstetrics.2024; 310(1): 1. CrossRef
Non-Excisional therapeutic modalities in vaginal intraepithelial neoplasia
Gonçalo Freitas, Antónia Costa
European Journal of Obstetrics & Gynecology and Reproductive Biology.2023; 284: 175. CrossRef
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus State
Vesna Kesic, Xavier Carcopino, Mario Preti, Pedro Vieira-Baptista, Federica Bevilacqua, Jacob Bornstein, Cyrus Chargari, Maggie Cruickshank, Emre Erzeneoglu, Niccolò Gallio, Murat Gultekin, Debra Heller, Elmar Joura, Maria Kyrgiou, Tatjana Madić, François
Journal of Lower Genital Tract Disease.2023; 27(2): 131. CrossRef
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus state
Vesna Kesic, Xavier Carcopino, Mario Preti, Pedro Vieira-Baptista, Federica Bevilacqua, Jacob Bornstein, Cyrus Chargari, Maggie Cruickshank, Emre Erzeneoglu, Niccolò Gallio, Murat Gultekin, Debra Heller, Elmar Joura, Maria Kyrgiou, Tatjana Madić, François
International Journal of Gynecological Cancer.2023; 33(4): 446. CrossRef
Analysis of related factors of cervical intraepithelial neoplasia complicated with vaginal intraepithelial neoplasia
Y.Y. Zhang, R. Xia, D. Chen, X. Zhang
Clinical and Translational Oncology.2022; 24(5): 902. CrossRef
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training
Amelia Barcellini, Mattia Dominoni, Francesca Dal Mas, Helena Biancuzzi, Sara Carla Venturini, Barbara Gardella, Ester Orlandi, Kari Bø
Frontiers in Medicine.2022;[Epub] CrossRef
Clinical outcomes of laser vaporization for vaginal intraepithelial neoplasia – A 20-year retrospective review
Mung Yuen He, Ellen Lok-man Yu, Sze Ki Hui, Yau Lung Fred Kung
European Journal of Obstetrics & Gynecology and Reproductive Biology.2022; 277: 101. CrossRef
Detection of high‐risk human papillomavirus infection and treatment of high‐grade vaginal intraepithelial neoplasia: A single‐institution study
Hyun‐Woong Cho, Jin Hwa Hong, Jae Kwan Lee
International Journal of Gynecology & Obstetrics.2021; 154(2): 227. CrossRef
UK national survey of the management of vaginal intraepithelial neoplasia
Mahalakshmi Gurumurthy, Simon Leeson, John Tidy, Margaret E. Cruickshank
Journal of Obstetrics and Gynaecology.2020; 40(5): 694. CrossRef
Vaginal carcinoma after cervical dysplasia
Mikel Gorostidi, Arantza Lekuona, Arantxa Juaristi, Glauco Baiocchi
International Journal of Gynecological Cancer.2020; 30(2): 265. CrossRef
Management options for vaginal intraepithelial neoplasia
Argirios Rountis, Vasilios Pergialiotis, Paraskevi Tsetsa, Alexandros Rodolakis, Dimitrios Haidopoulos
International Journal of Clinical Practice.2020;[Epub] CrossRef
Effect of Cyclophosphamide Treatment on Central and Effector Memory T Cells in Mice
Marcin Włodarczyk, Elżbieta Ograczyk, Magdalena Kowalewicz-Kulbat, Magdalena Druszczyńska, Wiesława Rudnicka, Marek Fol
International Journal of Toxicology.2018; 37(5): 373. CrossRef
Total vaginectomy for refractory vaginal intraepithelial neoplasia III of the vaginal vault
Ju Hyun Youn, Min Ah Lee, Woong Ju, Seoung Cheol Kim, Yun Hwan Kim
Obstetrics & Gynecology Science.2016; 59(1): 71. CrossRef
Brachytherapy for vaginal intraepithelial neoplasia
Agnieszka Zolciak-Siwinska, Ewelina Gruszczynska, Joanna Jonska-Gmyrek, Anna Kulik, Wojciech Michalski
European Journal of Obstetrics & Gynecology and Reproductive Biology.2015; 194: 73. CrossRef

15,567 View
202 Download
19 Web of Science
19 Crossref

First
Prev
Page of 1
Next
Last

Search